Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Allied Corp. | Director, 10%+ Owner | Common Stock | 4.78M | $2.25M | $0.47 | Apr 27, 2023 | Direct |
NYMOX PHARMACEUTICAL CORP | Director, 10%+ Owner | Common Stock | 4.78M | $2.25M | $0.47 | Apr 27, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NYMXF | NYMOX PHARMACEUTICAL CORP | Apr 25, 2023 | 2 | $36.8K | 4/A | Jun 26, 2023 | Director, 10%+ Owner |
NYMXF | NYMOX PHARMACEUTICAL CORP | Apr 25, 2023 | 1 | $18K | 4/A | May 18, 2023 | Director, 10%+ Owner |
ALID | Allied Corp. | Apr 25, 2023 | 2 | $36.8K | 4 | Apr 27, 2023 | Director, 10%+ Owner |
NYMXF | NYMOX PHARMACEUTICAL CORP | May 2, 2022 | 2 | $1.9M | 4 | May 6, 2022 | Director |